Hughes MS & Lentzsch S. (2023). Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL Amyloidosis. Dove Medical Press.
Chicago Style (17th ed.) CitationHughes MS and Lentzsch S. Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL Amyloidosis. Dove Medical Press, 2023.
MLA (9th ed.) CitationHughes MS and Lentzsch S. Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL Amyloidosis. Dove Medical Press, 2023.
Warning: These citations may not always be 100% accurate.